Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §112 only | 1 (25%) |
| Double-patenting + other | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHTERENGARTS, SAMANTHA L | 1 | 79.3% | +8.0% |
| RZECZYCKI, PHILLIP MATTHEW | 1 | 63.0% | +39.1% |
| GRAY, JESSICA | 1 | 0.0% | +0.0% |
| GOLDBERG, JEANINE ANNE | 1 | 45.9% | +40.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17630304 | MOLECULAR CLASSIFIERS FOR PROSTATE CANCER | GRAY, JESSICA | 146d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17612695 | PAN-CANCER TRANSCRIPTIONAL SIGNATURE | GOLDBERG, JEANINE ANNE | 366d overdue |
| 18288213 | HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) | RZECZYCKI, PHILLIP MATTHEW | — |
| Art Unit | Apps |
|---|---|
| 1682 | 2 |
| 1623 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18288222 | HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) | SHTERENGARTS, SAMANTHA L | 1623 | §103§112DP | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18288213 | HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) | RZECZYCKI, PHILLIP MATTHEW | 1625 | §103§112DPOther | Non-Final OA | — | Pending | Oct 25, 2023 |
| 17630304 | MOLECULAR CLASSIFIERS FOR PROSTATE CANCER | GRAY, JESSICA | 1682 | §101§112 | Final Rejection | 146d overdue | Pending | Jan 26, 2022 |
| 17612695 | PAN-CANCER TRANSCRIPTIONAL SIGNATURE | GOLDBERG, JEANINE ANNE | 1682 | §112 | Non-Final OA | 366d overdue | Pending | Nov 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial